Literature DB >> 23707898

The Drosophila ortholog of breast cancer metastasis suppressor gene, dBrms1, is critical for developmental timing through regulating ecdysone signaling.

Shilin Song1, Yuan Yuan, Jinfeng Lu, Qi Li, Zuoyan Zhu, Qichang Fan, Youfang Xue, Zhi-Chun Lai, Wenxia Zhang.   

Abstract

BRMS1 was first discovered as a human breast carcinoma metastasis suppressor gene. However, the mechanism of BRMS1 in tumor metastasis and its developmental role remain unclear. In this paper, we first report the identification of the Drosophila ortholog of human BRMS1, dBrms1. Through a genetic approach, the role of dBrms1 during development has been investigated. We found that dBrms1 is an essential gene and loss of dBrms1 function results in lethality at early developmental stages. dBrms1mutants displayed phenotypes such as developmental delay and failure to initiate metamorphosis. Further analysis suggests that these phenotypes are contributed by defective ecdysone signaling and expression of target genes of the ecdysone pathway. Therefore, dBrms1 is required for growth control by acting as a modulator of ecdysone signaling in Drosophila and is required for metamorphosis for normal development.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer metastasis suppressor 1; Brms1; Developmental timing; Drosophila; Ecdysone signaling

Mesh:

Substances:

Year:  2013        PMID: 23707898     DOI: 10.1016/j.ydbio.2013.05.012

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  2 in total

1.  Transforming growth factor-β1 regulates epithelial-mesenchymal transition in association with cancer stem-like cells in a breast cancer cell line.

Authors:  Yongfeng Jia; Di Wu; Fen Yun; Lin Shi; Nianrong Luo; Zhiyue Liu; Yonghong Shi; Qinnuan Sun; Lili Jiang; Shiqi Wang; Maolin Du
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Systematic Analysis of SIN3 Histone Modifying Complex Components During Development.

Authors:  Valerie L Barnes; Kelly A Laity; Maksymilian Pilecki; Lori A Pile
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.